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Radiotherapy is a part of cancer treatment. To improve its efficacy has been combined
with radiosensitizers such as antiangiogenic agents. Among the mechanisms of the
antitumor action of melatonin are antiangiogenic effects. Our goal was to investigate
whether melatonin may modulate the sensitivity of endothelial cells (HUVECs) to
ionizing radiation. Melatonin (1 mM) enhanced the inhibition induced by radiation
on different steps of the angiogenic process, cell proliferation, migration, and
tubular network formation. In relation with the activity and expression of enzymes
implicated in estrogen synthesis, in co-cultures HUVECs/MCF-7, radiation down-
regulated aromatase mRNA expression, aromatase endothelial-specific promoter I.7,
sulfatase activity and expression and 17β-HSD1 activity and expression and melatonin
enhanced these effects. Radiation and melatonin induced a significant decrease in
VEGF, ANG-1, and ANG-2 mRNA expression. In ANG-2 and VEGF mRNA expression
melatonin potentiated the inhibitory effect induced by radiation. In addition, melatonin
counteracted the stimulatory effect of radiation on FGFR3, TGFα, JAG1, IGF-1, and KDR
mRNA expression and reduced ANPEP expression. In relation with extracellular matrix
molecules, radiation increased MMP14 mRNA expression and melatonin counteracted
the stimulatory effect of radiation on MMP14 mRNA expression and increased TIMP1
expression, an angiogenesis inhibitor. Melatonin also counteracted the stimulatory
effect of radiation on CXCL6, CCL2, ERK1, ERK2, and AKT1 mRNA expression and
increased the inhibitory effect of radiation on NOS3 expression. In CAM assay, melatonin
enhanced the reduction of the vascular area induced by radiation. Melatonin potentiated
the inhibitory effect on the activation of p-AKT and p-ERK exerted by radiation.
Antiangiogenic effect of melatonin could be mediated through AKT and ERK pathways,
proteins involved in vascular endothelial (VE) cell growth, cell proliferation, survival,
migration, and angiogenesis. In addition, radiation increased endothelial cell permeability
and melatonin counteracted it by regulating the internalization of VE-cadherin. Radiation
has some side effects on angiogenesis that may reduce its effectiveness against
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tumor growth and melatonin is able to neutralize these negative actions of radiation.
Additionally, melatonin potentiated radiation-induced antiangiogenic actions on several
steps of the angiogenic process and enhanced its antitumor action. Our findings point
to melatonin as a useful molecule as adjuvant to radiotherapy in cancer treatment.
Keywords: melatonin, endothelial cells, radiation, HUVEC, aromatase
INTRODUCTION
The generation of new blood vessels is a fundamental
phenomenon that can be induced by pathological conditions as
cancer. Angiogenesis needs degradation of the vascular basement
membrane and the activation of endothelial cell proliferation,
migration and tube formation (Bergers and Benjamin, 2003).
Many studies suggest that inhibition of angiogenesis can reduce
the development of tumors (Bareschino et al., 2011; Viallard and
Larrivée, 2017). When the equilibrium between pro- and anti-
angiogenic factors is altered, the “angiogenic switch” is activated.
These factors, combined with endothelial cells, the extracellular
matrix and tumor cells modulate endothelial cell activities and
vessel stabilization (Bareschino et al., 2011; Dvorak et al., 2011;
Viallard and Larrivée, 2017). Vascular endothelial growth factor
(VEGF) and angiopoietins are the major pro-angiogenic factors
(Cook and Figg, 2010; Danza et al., 2013). In angiogenesis a
quantitatively and temporally coordinated dynamic equilibrium
between the synthesis of VEGF and angiopoietins is needed
(Bhadada et al., 2011).
Melatonin has oncostatic actions in diverse cancer types,
especially hormone-dependent tumors (Hill and Blask, 1998;
Cos and Sánchez-Barceló, 2000). Different mechanisms of
action explain melatonin’s ability to counteract cancer genesis
and growth. These involve indirect and direct antiestrogenic
actions, induction of apoptosis, antioxidant effects, epigenetic
effects, activation of the immunity, prevention of circadian
disruption, inhibition of telomerase activity, regulation of tumor
metabolism, and inhibition of angiogenesis (Cos et al., 1991;
Molis et al., 1994; Blask et al., 2003; González et al., 2007,
2012; Mediavilla et al., 2010; Alvarez-García et al., 2013a,b,c;
Reiter et al., 2017). Melatonin antiangiogenic effects are exerted
directly on several important proteins in this process such
as VEGF and angiopoietins (ANG-1 and ANG-2), by down-
regulating VEGF expression in breast cancer cells and reducing
the proliferation as well as the migration of endothelial
cells, disrupting tube formation and counteracting the VEGF-
stimulated capillary network formation (Alvarez-García et al.,
2013a,b; Cos et al., 2014; González-González et al., 2018).
Melatonin also shows indirect antiangiogenic effects, such
as the inhibition of some tumor growth factors (IGF, EGF,
and ET-1) which stimulate tumoral angiogenesis (Kajdaniuk
et al., 2002) and the neutralization of reactive oxygen species
which, in hypoxia, stabilize hypoxia-inducible factor HIF-α
(Fandrey and Genius, 2000).
Radiation therapy plays a main role in cancer treatment.
Although radiation has important positive effects in the
treatment of many tumors, there are acute and chronic side
effects that limit its use and affect the quality of life of
patients. For this reason, different radioprotective compounds,
such as antioxidants, corticosteroids or compounds containing
thiol/sulfhydryl/SH, and radiosensitizers have been used with
the aim of reducing these adverse effects in healthy tissue
and improving the tumor response to radiotherapy treatment
(Bagheri et al., 2018; Narmani et al., 2018). In order to bettering
radiotherapy efficacy there is an increasing interest in combined
radiotherapy with other therapies such as antiangiogenic therapy
or immunotherapy (Goedegebuure et al., 2019).
Melatonin is a natural compound regulator of malignant cell
growth that could have enhancing actions on the antineoplastic
effects of radiation therapy (Farhood et al., 2019). Different
in vitro and in vivo studies described that melatonin could
behave as radioprotector. They have showed the ability of
melatonin to reduce cytotoxic effects of ionizing radiation, such
as DNA damage, apoptosis, fibrosis, inflammation, infertility,
cataract, etc. (Vijayalaxmi et al., 2004). In addition, melatonin
is also able to increase the oncostatic effects of radiation
therapy. Both melatonin radioprotective and radiosensitive
effects make it a good candidate to employ in combination
to radiotherapy. Although studies on the mechanisms of
the radiosensitive effects of melatonin are very limited, it
has been suggested that the reduction of the DNA repair
response, changes in the metabolism of the cancer cell,
changes in estrogen biosynthesis, immunomodulatory actions
or activation of proapoptotic proteins such as p53, could be
some of the mechanisms involved in this process (Vijayalaxmi
et al., 2004; Najafi et al., 2017; Farhood et al., 2019). Since
melatonin has oncostatic actions in human breast cancer,
part of these antitumor actions are aimed to prevent the
formation of new vessels and also has beneficial effects
added with ionizing radiation, our objective in the present
study was to investigate the usefulness of melatonin as
adjuvant to ionizing radiation in different steps of the
angiogenic process. We analyzed the possible effects of
melatonin on angiogenesis in radiated human endothelial
cells in order to study whether this indolamine potentiates
antiangiogenic actions and/or neutralizes proangiogenic actions
induced by the radiation. To accomplish this, firstly, in radiated
human endothelial cells, we studied melatonin effects on cell
proliferation, migration of endothelial cells, formation of tubular
structures, endothelial cell permeability, activity and expression
of enzymes involved in estrogen biosynthesis, VEGF, and
angiopoietins gene expression (two of the main pro-angiogenic
factors). Secondly, we analyzed the influence of melatonin
on the expression of different genes involved in biological
processes of angiogenesis, by using a Human Angiogenesis RT2
ProfilerTM PCR Array. Those genes which mRNA expression was
significantly regulated by melatonin were analized by specific
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RT-PCR studies. In addition, we explored some intracellular
signaling pathways involved in melatonin effects. Finally, we
evaluated melatonin anti-angiogenic activity in vivo on the chick
embryo chorioallantoic membrane.
MATERIALS AND METHODS
Cells and Culture Conditions
Human umbilical vein endothelial cells (HUVECs) were obtained
from the American Tissue Culture Collection (Rockville, MD,
United States). They were maintained as monolayer cultures
in 58, 1 cm2 plastic culture plates in Vascular Cell Basal
Medium (VCBM) (ATCC, Rockville, MD, United States)
supplemented with endothelial cell growth kit-BBE (ATCC,
Rockville, MD, United States) which consisted on 2% fetal
bovine serum (FBS), 0.2% Bovine Brain Extract, 5 ng/ml rhEGF,
10 mM L-glutamine, 0.75 units/ml heparin sulfate, 1 µg/ml
hydrocortisone hemisuccinate, 50 µg/ml ascorbic acid, penicillin
(20 units/ml), and streptomycin (20 µg/ml) (Sigma-Aldrich,
Madrid, Spain) at 37◦ in a humid atmosphere containing 5% CO2.
To avoid genetic mutation and low viability, no more than five-six
passages of HUVECs were used (Alvarez-García et al., 2013b,c).
MCF-7 human breast cancer cells were purchased from
the American Tissue Culture Collection (Rockville, MD,
United States). They were maintained as monolayer cultures
in 75 cm2 plastic culture flasks in Dulbecco’s Modified
Eagle’s Medium (DMEM) (Sigma-Aldrich, Madrid, Spain)
supplemented with 10% FBS (PAA Laboratories, Pasching,
Austria), penicillin (20 units/ml) and streptomycin (20 µg/ml)
(Sigma-Aldrich, Madrid, Spain) at 37◦ in a humid atmosphere
containing 5% CO2 (Alvarez-García et al., 2013a).
Co-culture of HUVEC and MCF-7 Cells
Since it is known that the presence of malignant epithelial
cells in the culture enhances estrogen formation in endothelial
cells (Meng et al., 2001; Alvarez-García et al., 2012), in some
experiments we employed co-cultures of HUVECs and MCF-7.
Based on previous works (González-González et al., 2018) cells
were co-cultured using Falcon 6-multiwell plates and Falcon cell
culture inserts. HUVECs, which have been treated for a week
with melatonin 1 mM or its diluent, were plated (50 × 104
cells/well) on the bottom wells in VCBM supplemented with
2% FBS and incubated overnight. At the same time, MCF-
7 cells (40 × 104 cells), which have been treated for a week
with melatonin 1 mM or its diluent, were cultured on the
permeable membrane (0.45 µm) of the tissue-culture inserts
in DMEM supplemented with 10% FBS also for 24 h. Both
types of cells were cultured independently for 24 h. Then, MCF-
7 seeded inserts were moved over HUVECs cell cultures in
the 6-well plates in fresh VCBM supplemented with 2% FBS
to create the hanging co-culture setup. Cell to cell contact is
avoided but paracrine signaling take place between HUVECs
in the well and MCF-7 cells on the insert. After 24 h,
media were changed to VCBM supplemented with 2% FBS
or serum free, according to the experiment. Then, cells were
irradiated and incubated for 4 h to measure specific mRNA gene
expression or for 0.5 or 24 h to measure the different enzymatic
activities in HUVECs.
Ionizing Radiation Treatment
HUVEC and MCF-7 cells were exposed to X irradiation using a
model YXLON SMART 200 tube (Yxlon International, Hamburg,
Germany) at room temperature. Initially, we used different doses,
4, 6, 8, and 10 Gy, of radiation. For the rest of experiments,
as in previous works (Alonso-González et al., 2016), we used
8 Gy radiation as the optimal radiation dose. The radiation was
administered as a single dose of 8 Gy in an 11.5 cm× 8.5 cm field
size, 6-multiwell plates, at a dose rate of 0.92 Gy/min. The source-
half-depth distance was initially calculated to obtain a constant
dose rate of 0.92 Gy/min. Control cells were removed from the
incubator and were place for the same period of time into the
irradiator but without radiation.
Measurement of Cellular Proliferation
Since the reduction of tetrazolium salts is accepted as a
good way to study cell proliferation, we used the MTT
[3(4,5dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide]
method (Mosmann, 1983), as previously described (Alonso-
González et al., 2016). MTT was obtained from Molecular
Probes Inc. (Eugene, OR, United States). Cells were incubated
for 1 week in VCBM supplemented with 2% FBS containing
melatonin (1 mM) (Sigma-Aldrich, Madrid, Spain) or not. Then,
both melatonin pretreated and control cells were seeded into
96-multiwell plates at a density of 8 × 103 cells per well, and
incubated at 37◦C for 24 h. After irradiation cells were cultured
for 3 days and cell proliferation was measured reading absorbance
at 570 nm in a microplate reader (Labsystems Multiskan RC 351,
Vienna, VA, United States).
Measurement of Cellular Aromatase
Activity
Aromatase activity in HUVECs cells was measured by the
tritiated water release assay which is based on the formation
of tritiated water during aromatization of a labeled androgenic
substrate such as [1β-3H(N)]-androst-4-ene-3,17-dione
(Ackerman et al., 1981). HUVECs, which have been treated
for a week with melatonin 1 mM or its diluent, were co-
cultured with MCF-7 cells as indicated previously. Then, when
a homogenous monolayer of pre-confluent HUVECs was
reached, media were aspirated and changed to serum-free media
containing the labeled substrate 300 nM [1β-3H(N)]-androst-
4-ene-3,17-dione (NEN Life Science Products, Boston, MA,
United States) (75–80 Ci/nM) and cells were irradiated. After
24 h of irradiation, as we previously described (Alonso-González
et al., 2016), culture flasks were placed on ice for 15 min to
condense any water vapor and media were transferred to
tubes containing 0.25 ml ice-cold 30% tricholoroacetic acid
(w/v), vortexed and centrifuged at 1700 g for 15 min at 4◦C.
The supernatants were extracted with chloroform, vortexed
and centrifuged at 1700 g for 15 min at 4◦C. The resulting
aqueous supernatants were adsorbed with 5% dextran-coated
charcoal (Sigma-Aldrich, Madrid, Spain), vortexed, centrifuged
Frontiers in Physiology | www.frontiersin.org 3 July 2019 | Volume 10 | Article 879
fphys-10-00879 July 10, 2019 Time: 17:15 # 4
González-González et al. Melatonin and Radiosensitivity of Endothelial Cells
at 1700 g for 15 min at 4◦C and the supernatants were added
to vials with scintillation cocktail and counted in a beta counter
(Beckman LS 6000 IC, Fulleton, CA, United States). The
amount of radioactivity measured in [3H]-water was corrected
by substracting the blank values from each sample, obtained
by incubating dishes containing medium with the tritiated
androgen but no cells. The values were also corrected by taking
into account the fractional retention of tritium in medium water
throughout the processing, utilizing parallel dishes containing
medium plus known amounts of [3H]-water (NEN Life Science
Products, Boston, MA, United States) through incubation and
assay. The fractional retention of tritium in medium water
throughout the incubation and processing of samples was always
higher than 85%.
Measurement of Steroid Sulfatase (STS)
Activity
STS activity in HUVECs was analyzed by the formation of estrone
from a labeled substrate ([6,7-3H(N)]-estrone sulfate ammonium
salt) (Duncan et al., 1993). HUVECs, which have been treated for
a week with melatonin 1 mM or its diluent, were co-cultured with
MCF-7 cells as indicated previously. As we previously described
(Alonso-González et al., 2016), when a homogenous monolayer
of pre-confluent HUVECs was reached, media were replaced with
fresh ones (1 ml per plate) containing 20 nM [6,7-3H(N)]-estrone
sulfate ammonium salt (NEN Life Science Products, Boston, MA,
United States) (57.3 Ci / mM) and cells were irradiated. After 24 h
of irradiation, culture dishes were processed as earlier described
(Alonso-González et al., 2016).
Measurement of 17β-Hydroxysteroid
Dehydrogenase Type 1 (17β-HSD1)
Activity
Activity of 17β-HSD1 was studied in endothelial cells by the
formation of estradiol from a labeled substrate [2,4,6,7-3H(N)]-
estrone (Singh and Reed, 1991). HUVECs, which have been
treated for a week with melatonin 1 mM or its diluent, were
co-cultured with MCF-7 cells as indicated previously. Then,
when a homogenous monolayer of pre-confluent HUVECs
was reached, media were aspirated, changed for fresh ones
(1 ml per plate) containing 2 nM [2,4,6,7-3H(N)]-estrone
(NEN Life Science Products, Boston, MA, United States)
(100 Ci / mM) and cells were irradiated. After 30 min of
incubation, the media were processed as we previously described
(Alonso-González et al., 2016).
Human Angiogenesis RT2 ProfilerTM PCR
Array
A 96-well Human Angiogenesis RT2 ProfilerTM PCR Array
(Qiagen, United States) was used to perform a pathway-focused
gene expression profiling. Each well of the array contains all
the components required and designed to generate single, gene-
specific amplicons, testing the expression of 84 genes related to
angiogenesis (growth factors and receptors, adhesion molecules,
proteases, inhibitors and other matrix proteins, transcription
factors, cytokines, and chemokines), and five housekeeping
genes. Briefly, HUVECs, which have been treated for a week with
melatonin 1 mM or its diluent, were seeded into 60 × 15 mm
plates in VCBM supplemented with 2% FBS and incubated
at 37◦C for 24 h to allow for cell attachment. Then media
were replaced by fresh ones with 2% FBS and plates were
irradiated. After 4 h of incubation, total RNA was extracted
and reverse transcribed. The cDNA template was combined
with the appropriate amount of RT2 SYBR Green qPCR
Mastermix (Qiagen GmbH, Germany), aliquoted 25 µl to each
well of the same plate, and carried out the real-time PCR
cycling program in an MX3005P (Agilent, CA, United States)
according to the manufacturer’s instructions. Amplification was
initiated by 1 cycle at 95◦C for 10 min and then performed
for 40 cycles for quantitative analysis using the following
temperature profile: 95◦C for 30 s (denaturation); 60◦C for
60 s (annealing/extension). Dissociation curves were made to
confirm that only a single product was amplified. The Ct data
for each gene were analyzed using the Qiagen RT2 profiler
PCR array data analysis software. Data are showed as fold-
regulation between the experimental groups and the control
cells. Fold-change values less than one indicate a negative or
downregulation, and the fold-regulation is the negative inverse
of the fold-change.
Measurement of Specific mRNA Gene
Expression
Analysis of different genes mRNA expression in HUVECs were
carried out by real-time reverse transcription RT-PCR after cells,
which have been treated for a week with melatonin 1 mM
or its diluent, were irradiated and incubated for 4 h. The
total cellular RNA was isolated from HUVECs and purified
with the Nucleospin RNA II Kit (Machenery-Nagel, Düren,
Germany) following the manufacturer’s instructions. As we
previously described (Alonso-González et al., 2016), integrity
of RNA was assessed by electrophoresis in ethidium bromide-
stained 1% agarose-Tris-borate EDTA gels. The absorbance ratio
A260 nm/A280 nm was >1.8. For cDNA synthesis 0.5 µg of
total RNA was denatured at 65◦C for 10 min and reverse
transcribed for 50 min at 45◦C with cDNA Synthesis kit
(Bioline, London, United Kingdom) in a final volume of 20 µl
in the presence of 500 ng of oligo (dT) 12–18 primers. The
primers used for amplification (Sigma Genosys Ltd., Cambridge,
United Kingdom) are described in Table 1. As a control
quantification, s14 mRNA was used (Sigma Genosys Ltd.,
Cambridge, United Kingdom). RT-PCRs were performed in a
MX3005P system (Stratagene, La Jolla, CA, United States) using
Brilliant R© SYBR R© Green PCR Master Mix (Applied Biosystems,
Madrid, Spain) following the manufacturer’s instructions.
Amplifications were performed for 40 cycles using the following
temperature profile: 60◦C, 45 s (annealing); 72◦C, 30 s
(extension); and 95◦C, 30 s (denaturation). Melting curves
were performed to confirm that only a single product with no
primer-dimers was amplified. For the primers used there were
no differences between transcription efficiencies, and the fold-
change in each sample was calculated by the 2−11Ct method
(Livak and Schmittgen, 2001).
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TABLE 1 | Primers used for amplification of mRNA transcripts.
Human
gene
Sense primer (5′-3′) Antisense primer (5′-3′)
17β-HSD1 CTTATGCGAGAGTCTGGCGGTTC GGTATTGGTAGAAGCGGTGGAAGG
AKT1 AAGTACTCTTTCCAGACCC TTCTCCAGCTTGAGGTC
ANG1 GAAGGGAACCGAGCCTATTC AGGGCACATTTGCACATACA
ANG2 AAGAGAAAGATCAGCTACAGG CCTTAGAGTTTGATGTGGAC
ANPEP CCTTCATTGTCAGTGAGTTC CAGCAAAGAAGTTAAGGATGG
ARO GTCGTGGACTTGGTCATGC CGAGTCTGTGCATCCTTCC
CCL2 AGACTAACCCAGAAACATCC ATTGATTGCATCTGGCTG
CXCL6 CCTCTCTTGACCACTATGAG GTTTTGGGGTTTACTCTCAG
ERK1 GCCACCTTCTCTCACTTTGCTG CCCACATCCAATCACCCACA
ERK2 CAGCACCTCAGCAATGACCA TGCGGGAGAGAAAGCAAATAGT
FGFR3 GAAGATGCTGAAAGACGATG GCAGGTTGATGATGTTTTTG
IGF1 CCCAGAAGGAAGTACATTTG GTTTAACAGGTAACTCGTGC
JAG1 ACTACTACTATGGCTTTGGC ATAGCTCTGTTACATTCGGG
KDR GTACATAGTTGTCGTTGTAGG TCAATCCCCACATTTAGTTC
MMP-14 GATAAACCCAAAAACCCCAC CTCCTTGAAGACAAACATCTC
NOS3 CAACCCCAAGACCTACG CGCAGACAAACATGTGG
pI.7 AACACTCAGCTTTTTCCCAAC CTTGCTGATTTCACCCCTTT
STS TCCGTTCCTGCTTGTCTTGTC CCTGGTCCGATGTGAAGTAGATG
TGFα AGAAACAGTGGTCTGAAGAG ATTACAGGCCAAGTAGGAAG
TIMP1 CACCTTATACCAGCGTTATG TTTCCAGCAATGAGAAACTC
VEGFB GAAAGTGGTGTCATGGATAG ATGAGCTCCACAGTCAAG
S14 TCACCGCCCTACACATCAAAC TCCTGCGAGTGCTGTCAGAG
Western Blot Analysis: Immunodetection
of Protein Expression Levels of AKT,
pAKT, ERK, and pERK
Confluent cells were washed with PBS and proteins were
collected using RIPA buffer, containing 1% protease inhibitor
cocktail. The protein concentration was determined using the
method of Lowry (Sengupta and Chattopadhyay, 1993) in
the spectrophotometer (Multiskan ex, Thermo Scientific) at
a wavelength of 620 nm, using a standard curve of albumin.
The cellular proteins were then separated by SDS-PAGE and
transferred to a polyvinylidene fluoride (PVDF) membrane
(Bio-Rad) from the polyacrylamide gel. The membranes
were blocked by incubation (1 h at room temperature) in
TBS-T buffer (10 mM Tris–HCl, pH 7.6, 150 mM NaCl, and
0.05% Tween 20) with 3% bovine serum albumin (BSA).
Subsequently the membranes were incubated with the primary
antibody, first for 1 h at room temperature and then overnight
at 4◦C and under stirring, and then incubated with the
respective fluorescent secondary antibody for 30 min at room
temperature. The following antibodies were used: rabbit
anti-AKT antibody (Cell Signaling Technology, Danvers,
MA, United States), rabbit anti-P-AKT antibody (Santa
Cruz, CA, United States), mouse anti-ERK1/2 antibody (Santa
Cruz, CA, United States), rabbit anti-P-ERK1/2 antibody (Cell
Signaling Technology, Danvers, MA, United States), and
mouse anti-GAPDH antibody (Santa Cruz, CA, United States).
Protein bands were detected by incubating with anti-rabbit
IRDye- 680RD LI-COR Biotechnology, Lincoln, Nebraska,
United States Red (700 nm) or anti-mouse IRDye-800CW
LI-COR Biotechnology, Lincoln, Nebraska, United States
Green (800 nm). Fluorescence was detected using the LI-COR
Odyssey IR Imaging System V3.0 system (LI-COR Odyssey
Biosciences). The optical density of the bands was determined
with the ImageJ program.
Endothelial Cell Migration Assay: Wound
Healing Assay
Endothelial cell migration was studied as previously described
(Alvarez-García et al., 2013a). Briefly, HUVEC control or
melatonin treated for a week cells were cultured into 6-well
plates (Falcon) in VCBM supplemented with 2% FBS and were
allowed to reach full confluence. With a pipette tip a line of
cells was scraped away. Then, cells were washed with PBS and
irradiated. In the plates, four randomly selected views along
the scraped line were photographed using an ORCA R2 camera
(Hamamatsu Photonics, Massy Cedex, France) attached to a
microscope set Nikon Ti (Werfen Group, Barcelona, Spain) at
10 × magnification. Photomicrographs were taken every 10 min
during the course of the experiment, which was terminated
as soon as the wound was completely filled in vehicle treated
controls (after 10 h). Initial and final wound sizes were measured
using the Nis Elements v.3.8 software (Nikon, Tokyo, Japan) and
the difference between the two was used to determine migration
distance using the following formula: initial wound size minus
final wound size divided by two.
Endothelial Cell Differentiation Assay:
Endothelial Cell Capillary-Like Tube
Formation Assay
To study the formation of tubular structures in HUVECs we used
the in vitro Angiogenesis Assay Tube Formation Kit (Cultrex,
Trevigen Inc., Gaithersburg, MD, United States) according to
the supplier’s instructions, as previously described (Alvarez-
García et al., 2013a). Briefly, growth factor-reduced Basement
Membrane Extract (BME) was added to a 24-well plate and
polymerized for 1 h at 37◦C. Control and melatonin pretreated
cells for a week (3 × 105 per well) were then cultured in
VCBM with 2% FBS and irradiated. Four h later, tubular
structures in four random fields were photographed with a
camera Nikon Sight DS-SML1 (Sendai Nikon Corporation,
Miyagi, Japan) attached to a fluorescence microscope Nikon
Eclipse TS100 (Kurobane Nikon Co Ltd., Tochigi, Japan) at
4×. The length of the tubular network was measured using
ImageJ 1.45S software.
Vascular Permeability Assay
Endothelial permeability was studied by diffusing of 40 kDa
fluorescein isothiocyanate (FITC)-dextran through cells (Porcù
et al., 2016). HUVECs control or melatonin treated for a
week were grown to confluence on collagen-coated inserts.
Then, to stimulate endothelial cell permeability VEGF 4 ng/ml
was added to the plates and inserts and were radiated.
After 24 h, FITC-dextran solution was added. We measured
the fluorescence intensity of FITC-dextran that crossed the
endothelial monolayer at 30, 60, and 90 min by using a microplate
reader at 485/530 nm (Labsystems Multiskan RC 351, Vienna,
VA, United States).
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Immunofluorescence Assay
Immunolabeling was performed in control or melatonin treated
HUVECs grown on coverslips. Then, cells were irradiated and,
after 24 h, fixed in 100% methanol (5 min) at room temperature.
After washing carefully, crystals were placed in a Petri dish
and, creating a moist chamber, cells were permeabilized with
PBS contained 10% goat serum, 0.3 M glycine, 1% BSA and
0.1% tween for 1 h at room temperature. Primary antibody
staining was performed for rabbit policlonal anti-VE-cadherin
(ab33168) (Abcam, Cambridge, United Kingdom) at 1 µg/ml.
After several PBS washes, cells were incubated for 1 h at room
temperature with the secondary antibody conjugated with a
fluorochrome, FITC (Jackson ImmunoResearch Laboratories,
Inc., United States). After incubation, crystals were washed with
1× PBS, dried thoroughly and a drop of vectashield mounting
medium (Vector Laboratories, Peterborough, United Kingdom)
was added. Observation was made with a LSM51O laser confocal
microscope (Zeiss).
Chick Chorioallantoic Membrane (CAM)
Model of Angiogenesis
As an in vivo model for studying angiogenesis we used the CAM
assay as described elsewhere (Porcù et al., 2016). Fertilized eggs
were incubated at 37◦C in a humidified incubator for 3 days.
Hypodermic needles were used to remove 4 ml of egg albumin
to allow detachment of the developing CAM shell. At day 4, the
shells were covered with a transparent adhesive tape and a small
window sawed with scissors on the broad side directly over the
avascular portion of the embryonic membrane. At day 11, eggs
were irradiated at 3 Gy and alginate beads containing PBS, VEGF
and/or melatonin 1 mM per bead were grafted on the CAM.
VEGF 1.57 pM was used as a positive control whereas PBS was
used as a negative control. Chemical agents were dissolved in
1% dimethyl sulfoxide. After 72 h new blood vessels converging
toward the alginate were counted at 5 × magnification under a
STEMI SR stereomicroscope equipped with a 100 mm objective
with adapter ring 47070 (Zeiss) and fixed with 7% buffered
formalin and photographed.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism
software. The data are showed as the mean ± standard errors
of the mean (S.E.M.). Statistical differences between groups were
calculated by using one way analysis of variance (ANOVA),
followed by the Student-Newman–Keuls test. Results were
considered as statistically significant at p< 0.05.
RESULTS
Influence of Melatonin on Ionizing
Radiation-Induced Effects on Cell
Proliferation in Endothelial Cells
To study the influence of melatonin in the first step of angiogenic
process, we analyzed the modulation of melatonin pretreatment
on the antiproliferative effects of ionizing radiation in HUVECs.
According with previous findings, melatonin pretreatment at
1 mM induced an inhibitory effect on the proliferation of
endothelial cells (Figure 1). With radiation alone, the HUVECs
proliferation decreased (p < 0.001) to all doses of radiation
administered. Moreover, melatonin pretreatment for 7 days
before radiation induced a significant (p < 0.001) higher
decrease in cell proliferation in comparison with only radiated
cells (Figure 1).
Effects of Melatonin on Ionizing
Radiation-Induced Changes on
Endothelial Cell Migration
To continue studying the angiogenic process, we next
investigated the effects of melatonin pretreatment on the
migratory properties of endothelial cells in radiated cells by using
wound-healing assays. As showed in Figure 2, 8 Gy radiation
alone did not modified the percentage of migrated endothelial
cells in comparison to control cells. Melatonin pretreatment
decreased the distance migrated by endothelial cells when
compared to radiated cells alone.
Effects of Melatonin on Ionizing
Radiation-Induced Changes on HUVEC
Capillary Structure Formation
To mimic other step in the angiogenesis process, HUVECs were
seeded on matrigel matrix to study the ability of endothelial
cells to form a capillary network. Then, we studied whether
ionizing radiation was able to interfere with the process of
formation of tubes and the capacity of melatonin to modulate this
action. As shown in Figure 3 endothelial cells plated on matrigel
formed a large network of tubes after 4 h. Radiation significantly
(p< 0.001) decreased the tubular network formation. In radiated
cells, melatonin 1 mM pretreatment disrupted tube formation
even more and increased significantly the reduction of tubule area
induced by ionizing radiation.
Influence of Melatonin on Ionizing
Radiation-Induced Effects on Activity
and Expression of Enzymes Involved in
Local Estrogen Biosynthesis in
Endothelial Cells
The role of estrogens in the growth of breast cancer with
pleiotropic effects on vascular tissue led us to study the
modulation of melatonin on ionizing radiation-induced effects
on activity and expression of several enzymes involved in
local synthesis of estrogens in endothelial cells. Since our
HUVEC cell line stock showed a low activity and expression
of the enzymes implicated in estrogen synthesis and it is
known that the presence of malignant epithelial cells in the
culture enhances estrogen production in endothelial cells,
we employed co-cultures of HUVECs and MCF-7 cells to
improve the activity and expression of the enzymes. Firstly, we
studied the influence of melatonin pretreatment on ionizing
radiation-induced effects on aromatase activity in HUVECs
incubated with tritiated androstenedione. Radiation did not
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FIGURE 1 | Melatonin increased radiation-induced effects on cell proliferation in endothelial cells. Cells were incubated in medium supplemented with 2% FBS
containing melatonin 1 mM (M) or not for 1 week. At that time, both melatonin pretreated and control cells were seeded into 96-multiwell plates at a density of
8 × 103 cells per well, and incubated at 37◦ for 24 h. Then, cells were irradiated with different doses, 4 (R-4), 6 (R-6), 8 (R-8), and 10 (R-10) Gy. After irradiation cells
were cultures for 3 days and cell proliferation was measured by the MTT method. Data are expressed as the percentage of the control group (Mean ± SEM). a,
p < 0.001 vs control; b, p < 0.001 vs R-4; c, p < 0.001 vs R-6; d, p < 0.001 vs R-8; and e, p < 0.001 vs R-10.
FIGURE 2 | Effects of melatonin (M) and radiation (R) on endothelial cell migration analyzed through the wound healing assay. Representative photomicrographs of
initial and after 10 h are shown at 10 × magnification and migration distance was measured as described in Material and Methods. Migrated area data shown are
expressed as Mean ± SEM of four experiments. a, p < 0.05 vs C (control); b, p < 0.01 vs R.
Frontiers in Physiology | www.frontiersin.org 7 July 2019 | Volume 10 | Article 879
fphys-10-00879 July 10, 2019 Time: 17:15 # 8
González-González et al. Melatonin and Radiosensitivity of Endothelial Cells
modified the aromatase activity of HUVECs. However, melatonin
pretreatment decreased significantly aromatase activity in the
presence or not of radiation (Figure 4A). Then, we studied
the ionizing radiation-induced effects on aromatase expression.
The mRNA expression of aromatase was significantly reduced
by radiation. Melatonin pretreatment at 1 mM exhibited a
significant and potent decrease in aromatase mRNA expression
and increased significantly the inhibitory effect induced by
ionizing radiation (Figure 4B).
To determine whether the aromatase promoter mainly
active in vascular endothelial (VE) cells in breast cancer,
the aromatase-promoter I.7, is involved in the regulation
of aromatase expression, we used RT-PCR to amplify the
aromatase endothelial-specific promoter I.7 transcripts from
RNA extracted from HUVECs. As shown in Figure 4C, radiation
significantly downregulated the aromatase-promoter I.7 and
melatonin enhanced this inhibitory effect.
In a second set of experiments, we studied the influence
of melatonin on ionizing radiation-induced effects on STS
activity and mRNA expression, the enzyme responsible
for converting estrogen sulfates into estrone and estradiol.
Radiation induced a significant inhibition of the STS activity
and expression. Melatonin pretreatment induced a significant
(p < 0.001) higher down-regulation in the STS activity and
expression (Figures 5A,B).
Next, we assessed the influence of melatonin on ionizing
radiation-induced effects on 17β-HSD1 activity and mRNA
expression, the enzyme that catalyze the conversion of the
FIGURE 3 | Potentiation by melatonin (M) of radiation (R)-induced effects on HUVEC capillary structure formation. HUVECs control (C) and melatonin pretreated cells
for a week were seeded on growth factor-reduced BME in medium supplemented with 2% FBS and irradiated. After 4 h of incubation, tubular structures were
photographed and tubule area was measured as described in see section “Material and Methods.” Tubule area data are expressed as the percentage of the control
group (mean ± SEM). a, p < 0.001 vs C (control); and b, p < 0.05 vs R.
FIGURE 4 | Effects of melatonin on radiation-induced changes on aromatase activity and expression and aromatase promoter 1.7 mRNA expression in endothelial
cells. HUVECs treated for a week with melatonin 1 mM or its diluent were co-cultured with MCF-7 cells as indicated in see section “Material and Methods.” (A) When
a homogenous monolayer of pre-confluent HUVECs was reached, media were aspirated and changed to serum-free media containing the labeled substrate 300 nM
[1β-3H(N)]-androst-4-ene-3,17-dione and irradiated. After 24 h of incubation, aromatase activity was measured as described in material and methods. (B,C) Control
and melatonin pretreated endothelial cells were irradiated and incubated for 4 h. The total cellular RNA was isolated from cells and reverse transcribed. cDNA was
subjected to PCR using specific primers for aromatase and aromatase promoter 1.7 or S14. Data are expressed as the percentage of the control group
(Mean ± SEM). C, control; M, melatonin; and R, radiation. a, p < 0.001 vs C (HUVEC); b, p < 0.05 vs C (HUVEC); c, p < 0.001 vs R (HUVEC); d, p < 0.05 vs C
(HUVEC/MCF-7); e, p < 0.001 vs C (HUVEC/MCF-7); and f, p < 0.05 vs R (HUVEC/MCF-7).
Frontiers in Physiology | www.frontiersin.org 8 July 2019 | Volume 10 | Article 879
fphys-10-00879 July 10, 2019 Time: 17:15 # 9
González-González et al. Melatonin and Radiosensitivity of Endothelial Cells
relatively weak estrone into the more potent estradiol. Both
radiation and melatonin pretreatment decreased 17β-HSD1
activity. Melatonin pretreatment enhanced the inhibitory effect
induced by the radiation on 17β-HSD1 activity (Figure 5C).
When we studied 17β-HSD1 mRNA expression in endothelial
cells, we found that melatonin and radiation also reduced
its expression. Melatonin also enhanced the inhibitory effect
induced by the radiation (Figure 5D).
Effects of Melatonin on
Radiation-Induced Effects on mRNA
Expression of Some of the Main
Pro-angiogenic Factors, Such as VEGF
and Angiopoietins
To study whether the effects in endothelial cell proliferation could
be due to a downregulation of some of the main angiogenic
factors, such as VEGF, ANG-1, and ANG-2, we measured
ANG-1, ANG-2, and VEGF mRNA expression by RT-PCR.
Radiation induced a significant decrease in ANG-1, ANG-2,
and VEGF mRNA expression (Figures 6A–C). Melatonin had
the same inhibitory effects as radiation. In ANG-2 and VEGF
mRNA expression, melatonin pretreatment induced a significant
downregulation of the expression and potentiated the inhibitory
effect induced by radiation (Figures 6B,C).
Effects of Melatonin on Changes
Induced by Radiation on Gene
Expression Related With Angiogenesis
Since the changes induced by radiation on gene expression
related with angiogenesis are quite unknown, we used the
Human Angiogenesis RT2 ProfilerTM PCR Array to determine
the changes induced by ionizing radiation either alone or in
combination with melatonin (1 mM) on the gene expression
of 84 genes related to angiogenesis. As shown in Figure 7,
having as criteria a change of at least 2-fold either with radiation
alone or in combination with melatonin (in comparison with
the expression of untreated control cells), radiation upregulated
the expression of 18 genes and downregulated the expression
of 20 genes. Melatonin alone downregulated the expression
of 25 genes and upregulated the expression of 3 genes. In
combination with radiation melatonin induced a downregulation
of the expression of 26 genes and an upregulation of the
expression of 8 genes. Of all of them we chose those that had
been altered in two or more array membranes, excluding those
that we had previously studied (VEGF, ANG-1, and ANG-2)
and those about which there is already a lot of information
about its modulation by melatonin. Figure 7 shows the effect of
radiation in the presence or not of melatonin on the most altered
angiogenic factors.
Of the growth factors and receptors that behave as angiogenic
factors, radiation increased FGFR3, IGF-1, JAG1, TGFα, and
KDR mRNA expression. Melatonin counteracted this stimulatory
effect of radiation and reduced ANPEP expression in comparison
with only radiated cells (Figure 8A).
Of the proteases, inhibitors and other matrix proteins involved
in angiogenesis, radiation increased MMP14 mRNA expression.
Melatonin counteracted the stimulatory effect of radiation on
MMP14 mRNA expression and increased TIMP1 expression in
radiated cells (Figure 8B).
Of other angiogenic factors involved in angiogenesis, radiation
increased CXCL6, CCL2, ERK1, ERK2, and AKT1 mRNA
expression and decreased NOS3 mRNA expression. Melatonin
counteracted the stimulatory effect of radiation on CXCL6,
CCL2, ERK1, ERK2, and AKT1 mRNA expression. Melatonin
increased significantly the inhibitory effect of ionizing radiation
on NOS3 expression (Figure 8C).
Effects of Melatonin on Changes
Induced by Radiation on AKT and ERK
Signal Pathways
Radiation markedly inhibited the activation of p-AKT and
p-ERK, whereas no change of total AKT or ERK protein
expression level was found. Melatonin pretreatment (1 mM)
significantly increased the inhibitory effect of radiation on p-AKT
and p-ERK (Figure 9).
Effects of Melatonin on Ionizing
Radiation-Induced Changes on
Endothelial Cell Permeability
To study whether the use of melatonin as adjuvant to
radiotherapy could also have an effect on vessel normalization,
we investigated the effects of melatonin pretreatment on
the permeability of HUVECs in radiated cells. As showed
in Figure 10, 8 Gy radiation alone increased endothelial
cell permeability. Melatonin counteracted significantly the
stimulatory effect of radiation.
Since melatonin decreased endothelial cell permeability and
VE-cadherin is the major tight junction proteins needed to
maintain the endothelial cell barrier, we studied the effect of
melatonin on VE-cadherin distribution by immunostaining.
Control cells showed continuous VE-cadherin staining in cell
to cell contact. Radiation disrupted this pattern and led to
intracellular accumulation of VE-cadherin with shortening of
the width of VE-cadherin-positive areas. Melatonin prevented
radiation-mediated VE-cadherin internalization from the
cell surface and increased VE-cadherin staining at cell-cell
junctions (Figure 10).
Influence of Melatonin on
Radiation-Induced Effects on New
Formed Blood Vessels in an in vivo
Angiogenesis Assay
The new formed blood vessels branch points were studied
in the chick CAM assay, an in vivo angiogenesis assay. As
showed in Figure 11, VEGF alone showed a potent angiogenic
response. Radiation significantly decreased the VEGF-induced
angiogenesis. Melatonin increased significantly (p < 0.001) the
reduction of the vascular area induced by radiation.
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FIGURE 5 | Effects of melatonin pretreatment on radiation-induced changes on STS and 17β-HSD1 activity and expression in endothelial cells. Melatonin 1 mM or
its diluent pretreated endothelial and MCF-7 cells for a week were plated on the co-culture as described in material and methods. (A) When a homogenous
monolayer of pre-confluent HUVECs was reached, media were aspirated and changed to serum-free media containing the labeled substrate 20 nM
[6,7-3H(N)]-estrone sulfate ammonium salt and radiated. After 24 h of radiation, sulfatase activity was measured as described in material and methods. (C) When a
homogenous monolayer of pre-confluent HUVECs was reached, media were aspirated and changed for fresh ones containing 2 nM [2,4,6,7-3H(N)]-estrone (100
Ci/mM) and cells were irradiated. After 30 min of incubation, 17β-HSD1 activity was measured as described in material and methods. (B,D) Control and melatonin
pretreated endothelial cells were irradiated and incubated for 4 h. The total cellular RNA was isolated from cells and reverse transcribed. cDNA was subjected to
PCR using specific primers for STS, 17β-HSD1 or S14. Data are expressed as the percentage of the control group (Mean ± SEM). C, control; M, melatonin; and R,
radiation. a, p < 0.001 vs C; and b, p < 0.001 vs R.
DISCUSSION
Radiotherapy is a treatment option in more than half of patients
with malignant tumors. One important objective in radiobiology
is to increase the sensitivity of malignant cells to the radiotherapy
and, at the same time, to preserve normal cells (Allison and
Dicker, 2014). The use of radiosensitizers can decrease side
effects in healthy tissues and improve cancer cell response
to radiotherapy. Some of the radiosensitizers that has been
combined with the radiation are antiangiogenic agents. Since
tumor vascular neo-angiogenesis has an outstanding role in
tumor ontogenesis and progression, the inhibition of tumoral
angiogenesis has also become an anticancer strategy in line
with other treatments, such as radiotherapy, chemotherapy and
surgery (Wang et al., 2015). Melatonin has been described as
an inhibitor of neoplastic growth through different mechanisms
that can increase the therapeutic effects of ionizing radiation
as well as chemotherapy (Martínez-Campa et al., 2017; Najafi
et al., 2017; Farhood et al., 2019). Among the mechanisms of the
antitumor action of melatonin are antiangiogenic effects, which
has proven useful in breast cancer treatment in combination with
some chemotherapeutic drugs (Alvarez-García et al., 2013b,c;
Martínez-Campa et al., 2017; Alonso-González et al., 2018).
Therefore, in the current study, we investigated the effects of
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FIGURE 6 | Effects of melatonin on radiation-induced changes on mRNA expression of some of the main pro-angiogenic factors, ANG-1 (A), ANG-2 (B), and VEGF
(C). HUVECs treated for a week with melatonin 1 mM or its diluent were co-cultured with MCF-7 cells, irradiated and incubated for 4 h, as indicated in material and
methods. The total cellular RNA was isolated from cells and reverse transcribed. cDNA was subjected to PCR using specific primers for VEGF, ANG-1, ANG-2, or
S14. Data are expressed as the percentage of the control group (mean ± SEM). C, control; M, melatonin; and R, radiation. a, p < 0.001 vs C; b, p < 0.001 vs R;
and c, p < 0.05 vs M.
ionizing radiation on different steps of the angiogenic process
and studied the modulation of these actions by melatonin at
endothelial cell level.
The present study demonstrates that melatonin potentiates
antiangiogenic actions and neutralizes proangiogenic actions
induced by ionizing radiation. We used different assays to
study different aspects of angiogenic behavior. The first step of
angiogenesis is the proliferation of endothelial cells. Radiation,
at 4, 6, 8, or 10 Gy, decreased endothelial cell proliferation,
as it has been previously reported, without large differences
between the different doses of radiation, probably because the
incubation time of 3 days was short (Kargiotis et al., 2010;
Kim et al., 2015). Melatonin at 1 mM concentration alone,
according with previous findings, induced an inhibitory effect on
the proliferation of endothelial cells (Alvarez-García et al., 2013c).
We used this melatonin concentration because was the most
effective doses in endothelial cells in previous works (Alvarez-
García et al., 2013b,c). In addition, melatonin pretreatment
potentiated the inhibitory effect on cell proliferation induced
by ionizing radiation. This potentiation of the antiproliferative
effects of radiation on endothelial cell agrees with recent
findings in which melatonin enhanced the antiproliferative effect
induced by ionizing radiation, on human breast cancer cells,
and modulated changes induced by radiation in gene expression
involved in double-strand DNA break repair and estrogen
biosynthesis (Alonso-González et al., 2015, 2016, 2018). We
then analyzed the changes induced by ionizing radiation in
other steps of the angiogenesis process like endothelial cells
migration or the tubular network formation. Cell irradiation
have been reported that inhibits HUVECs migration and the
three-dimensional organization of the endothelial cells into
capillary-like tubes (Kargiotis et al., 2010; Fokas et al., 2012;
Kaffas et al., 2014; Kim et al., 2015). In this study, we
found that ionizing radiation did not significantly modified
the migration of endothelial cells but, effectively, decreased the
tubular network formation. The different effects of ionizing
radiation on the tumor vasculature can be explained by their
dependence on the dose and scheduling of radiation. High doses,
above 10 Gy, induces vascular damage that ends in cell death.
However, fractionated low dose radiation, like daily fractions
of up to 2 Gy induces a positive effect on tumor vasculature
(Goedegebuure et al., 2019). Melatonin reduced endothelial cell
migration and significantly enhanced the reduction of tubule area
induced by radiation. Our results are in agreement with those
that describe antiangiogenic effects of melatonin in endothelial
cell cultures. Melatonin inhibits cell migration, disrupts tube
formation, counteracts the VEGF-stimulated tubular network
formation by HUVECs and disintegrates preformed capillary
network (Alvarez-García et al., 2013a). Other antiangiogenic
compounds have obtained similar effects that melatonin, thus,
the combination of ionizing radiation with sunitinib, an inhibitor
of angiogenesis, enhanced the radiation response of endothelial
cells and completely inhibited tube formation (Kaffas et al.,
2014). The anti-angiogenic compound SU5416 has shown
radiosensitizing effects in endothelial cells. These effects have
been associated with inhibition of cell survival, inhibition of
DNA repair activity, stimulation of apoptosis, inhibition of
cell migration and invasion and suppression of angiogenesis
(Kim et al., 2015).
Estrogens stimulate endothelial cell proliferation in vitro
and in vivo, enhance adhesion of endothelial cells to various
matrix proteins and increase cell migration, thus promoting
angiogenesis (Trenti et al., 2018). The mechanisms responsible
for the proangiogenic effect of estrogens have been widely
investigated and appear to be largely mediated by ERα activation.
In breast cancer, a clear association has been described between
estrogen, ER expression by endothelial cells, angiogenic activity
and/or tumor invasiveness (Trenti et al., 2018). For this reason,
we considered interesting to study the effects of ionizing radiation
and its combination with melatonin on activity and expression
of aromatase, sulfatase and 17β-HSD1, enzymes involved in
estrogen biosynthesis in endothelial cells. In co-cultures of
endothelial and mammary tumor cells, radiation downregulated
aromatase mRNA expression, the aromatase endothelial-specific
promoter I.7, sulfatase activity and expression and 17β-HSD1
activity and expression. Melatonin potentiated the effect induced
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FIGURE 7 | Genes induced or repressed at least two-fold in endothelial cells
treated either with radiation and/or melatonin 1 mM for 4 h. Pathway-focused
gene expression profiling was performed using a 96-well human breast
cancer Human Angiogenesis RT2 ProfilerTM PCR Array. Black columns
indicate the percentage of upregulated genes and gray columns indicate the
percentage of downregulated genes in each category.
by ionizing radiation. At this moment, it is not described the
effect of ionizing radiation on the estrogen biosynthesis in
endothelial cells. It has been reported only that chemotherapeutic
agents like docetaxel decrease intratumoral aromatase mRNA
levels in breast tumors, suggesting that antitumor activity of
chemotherapy is mediated, at least in part, through suppression
of intratumoral estrogens synthesis (Miyoshi et al., 2004).
However, it is well known that melatonin regulates the synthesis
and transformation of androgens and active estrogens in
human breast cancer cells and endothelial cells, through the
inhibition of aromatase, sulfatase and 17β-HSD1 activity and
expression (Cos et al., 2008; Alvarez-García et al., 2013b;
Alonso-González et al., 2016).
We also studied melatonin effects on some of the main
pro-angiogenic factors. VEGF is the most active endogenous
pro-angiogenic factor, which induces angiogenesis directly on
the endothelial cells (Liang and Hyder, 2005). More recently,
the ANG/Tie2 receptor signaling are considered together with
VEGF the main regulators of different mechanisms of tumor
vascularization that act in a complementary and coordinated
way (Thomas and Augustin, 2009; Danza et al., 2013). Both
are ligands of the Tie2 tyrosine kinase receptor. ANG-1 binds
to Tie2 receptor and induces vessel maturation and stabilizes
tumor vasculature. However, ANG-2 competes with ANG-1 for
Tie2 binding, causing vessel regression in the absence of VEGF,
whereas it promotes angiogenesis in the presence of VEGF
(Holash et al., 1999; Fagiani and Christofori, 2013). Radiation
and melatonin induced a significant decrease in ANG-1, ANG-
2, and VEGF mRNA expression. Melatonin pretreatment before
irradiation potentiated the inhibitory effect induced by radiation
on ANG-2 and VEGF expression. It is known that high dose
of radiation inhibits angiogenesis by inhibiting endothelial cell
survival, proliferation, migration and tube formation. However,
low dose of radiation can also induce VEGF production and
protect tumor blood vessels, resulting in tumor radioresistance
(Gorski et al., 1999; Kobayashi and Lin, 2006). Depriving
endothelial cells of VEGF may represent an important strategy
to increase the antitumor effects of ionizing radiation and
many studies describe that irradiation after antiangiogenic
therapy sensitize endothelial cells and enhances the effect of
radiotherapy (Gorski et al., 1999; Kobayashi and Lin, 2006).
The overexpression of VEGF has been related with an increase
of endothelial cell survival and tumor radioresistance (Gorski
et al., 1999; Gupta et al., 2002). Wachsberger et al. (2003)
proposed that enhancement of radiation response occurs through
inhibition of VEGF-induced protection against radiation damage
to endothelial cells. It is known that melatonin decreases the
production and the expression of VEGF in human breast
cancer cells and coordinates at the same time a downregulation
of angiopoietins with a reduction of VEGF in cocultures of
endothelial and breast cancer cells (Alvarez-García et al., 2013b,c;
González et al., 2017). Melatonin has antiangiogenic actions by
downregulation of VEGF in several kind of tumors, such as
neuroblastoma (González et al., 2017), breast cancer (Alvarez-
García et al., 2013b,c), ovarian (Zonta et al., 2017), gastric (Wang
et al., 2016), pancreatic (Cui et al., 2012), prostatic (Sohn et al.,
2015), or hepatocarcinoma (Colombo et al., 2016). In addition,
in Walker 256 carcinoma and mandibular salivary gland of rats
during paraneoplastic process, melatonin in combination with
cyclophosphamide reduced tumor growth and the expression
of VEGF-A in tumor and salivary gland, a marker in early
diagnostics of neoplasms and estimation of the efficiency of
antitumor therapy (Ovsyanko et al., 2015). The potentiation by
melatonin of the inhibitory effect induced by radiation on VEGF
expression could be an important mechanism through which
melatonin increases tumor radiosensitivity.
When we examined the changes in the expression of 84
genes related to angiogenesis in endothelial cells irradiated in
the presence or not of melatonin, we found that, in relation
with the regulation of angiogenic factors, radiation increased
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FIGURE 8 | Effect of radiation in the presence or not of melatonin 1 mM on the genes selected for analysis by specific RT-PCR: (A) FGFR3, IGF-1, JAG1, TGFα,
KDR, and ANPEP as angiogenic growth factors, (B) MMP14 and TIMP1 as extracellular matrix molecules, (C) CXCL6, NOS3, CCL2, ERK1, ERK2, and AKT1 as
cytokines and other angiogenic factors. Data are expressed as the percentage of the control group (Mean ± SEM). C, control; M, melatonin; and R, radiation. a,
p < 0.05 vs C; b, p < 0.001 vs C; c, p < 0.05 vs R; and d, p < 0.001 vs R.
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FIGURE 9 | Effects of radiation in the presence or not of melatonin 1 mM on
AKT and ERK signaling pathways. Western blot showing protein levels for
AKT, ERK, p-AKT, p-ERK, and GADPH as a control. Data are expressed as
the percentage of the control group (Mean ± SEM). C, control; M, melatonin;
and R, radiation. a, p < 0.05 vs C; and b, p < 0.05 vs R.
JAG1, IGF-1, KDR, FGFR3, and TGFα expression. JAG1 has
been implicated in different aspects of cancer biology including
tumor angiogenesis, neoplastic cell growth and the metastatic
process (Grochowski et al., 2016). JAG1 mRNA expression is
upregulated in breast cancer and has been correlated with a poor
overall breast cancer survival (Reedijk et al., 2005; Grochowski
et al., 2016). IGF-1 and KDR are involved in promoting tumoral
cell growth, neoplastic transformation processes, angiogenesis,
cell migration and tumor progression (Oh et al., 2002; Liang
and Hyder, 2005). FGFR3 expression is associated with poor
FIGURE 10 | Effects of melatonin on radiation-induced changes on
endothelial cell permeability and VE-cadherin internalization. (A) HUVECs were
seeded onto 0, 1% collagen-coated 24-well insert wells until they reached full
confluence. Then, VEGF 4 ng/ml was added to the plates and inserts and
they were radiated. After 24 h, FITC-dextran solution was added and its
passage into the lower chamber was measured at 90 min. Data are
expressed as the percentage of the control group (Mean ± SEM). a, p < 0.05
vs C; and b, p < 0.01 vs R. (B) HUVECs grown on coverslips were irradiated
and, after 24 h, processed for immunofluorescence studies of the
internalization of VE-cadherin as described in material and methods. C,
control; M, melatonin; and R, radiation.
prognosis in breast cancer (Wang and Ding, 2017). In addition,
recent studies also indicate that FGFR3 may function via a
common molecular pathway causing breast cancer and may
be a candidate therapeutic target in FGFR3-associated breast
cancer (Wang and Ding, 2017). TGFα acts synergistically with
TGFβ promoting cell proliferation (Gacche and Meshram, 2013).
In our study melatonin counteracted the stimulatory effect of
radiation on the five angiogenic factors. It should be noted that
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FIGURE 11 | In vivo effect of melatonin on the radiation-induced actions on the VEGF-stimulated angiogenesis in the chorioallantoic membrane assay. Eggs were
irradiated and alginate beads with VEGF 1.57 pM, as stimulator of blood vessel formation, with and without melatonin 1 mM, were placed on the chorioallantoic
membrane on day 11 of development. On day 14, newly formed blood vessel converging toward the alginates were counted at microscopic level. (A) Representative
images of CAM. (B) Vessel number data shown are expressed as mean ± SEM. C, control; M, melatonin; VEGF, vascular endothelial growth factor; and R, radiation.
a, p < 0.001 vs C; b, p < 0.05 vs C; c, p < 0.001 vs VEGF; and d, p < 0.001 vs R.
the stimulatory effects of radiation on these angiogenic factors
expression could be considered as a negative effect because they
are increasing angiogenesis. However, melatonin counteracted
this negative effect and neutralized this action.
In regard to the modulation of extracellular matrix molecules
involved in angiogenesis, radiation increased MMP14 expression.
MMP14 is a metalloproteinase which has been found to play
a critical role in cancer invasion and metastasis by cleaving
extracellular matrix and basement membrane proteins, activating
proMMP-2 and -13, inducing the activation of growth factors,
and enhancing cell migration (Seiki, 2003). In our study,
melatonin counteracted the stimulatory effect of radiation on
MMP14 expression and increased TIMP1 expression. TIMP1
influences processes as survival, migration or proliferation
through indirect mechanisms based on the inhibition of
metalloproteinases and its stimulation can prevent angiogenesis
in vivo (Zacchigna et al., 2004; Ries, 2014). Our results are
in accordance with those of Ordoñez et al. (2014) which
described that melatonin regulates motility and invasiveness of
human HepG2 hepatocarcinoma cells, through a mechanism
that involves TIMP-1 upregulation and attenuation of MMP-9
expression and activity via NF-jB signal pathway inhibition.
Finally, in relation with other angiogenic factors involved in
angiogenesis radiation increased CXCL6, CCL2, ERK1, ERK2,
and AKT1 expression and decreased NOS3 expression. CXCL6
mediates breast cancer progression by pERK1/2-dependent
mechanisms and stimulates endothelial cell proliferation and
migration (Ma et al., 2017). CCL2 induces the invasive phenotype
of human breast epithelial cells (Lee et al., 2018). It has also
been described a correlation between NOS3 expression and
progression of malignancy in human breast cancer (Vannini
et al., 2015). ERK1, ERK2, and the protein kinase AKT1 are
mediators for several signal transduction pathways through its
ability to phosphorylate different downstream targets directly
involved in cellular processes related with vascular remodeling,
including proliferation, cell survival, and metabolism (Yu et al.,
2015). Melatonin counteracted the stimulatory effect of radiation
on CXCL6, CCL2, ERK1, ERK2, and AKT1 expression and
increased significantly the inhibitory effect of ionizing radiation
on NOS3 expression. This result agree with previous findings,
in hepatocellular carcinoma cell lines, where melatonin also
downregulated CXCL6 at pharmacologic concentrations (Lin and
Chuang, 2010). In human endothelial cells, intracellular signaling
pathways, such as MAPK, PI3K/ AKT, ERK1/2 pathways,
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involved in VE cell proliferation, survival and migration, are
inactivated by melatonin which finally lead to the decrease
of endothelial cell proliferation (Cui et al., 2008). Hypoxia-
induced migration of endothelial cells is inhibited through
the inhibition of ERK/Rac1 pathway (Yang et al., 2014).
Recently, regulation by melatonin of main signal transduction
pathways, such as AKT and MAPK, has been also related
with reduction of drug resistance in cancer chemotherapy
(Asghari et al., 2018). Another melatonin inhibitory mechanism
in tumoral angiogenesis has also been previously related
with the inhibition of sphingosine kinase 1 which affect the
stability of HIF-1α through AKT-GSK-3β pathway (Cho et al.,
2011). In our study, melatonin counteracted the increase of
AKT1 and ERK 1/2 expression and potentiated the inhibitory
effect on the activation of p-AKT and p-ERK exerted by
radiation. These results suggest that the antiproliferative and
antiangiogenic effect of melatonin could be mediated through
AKT and ERK pathways, two of the intracellular signaling
pathways involved in many important physiological processes,
such as VE cell growth, cell proliferation, survival, migration
and angiogenesis.
Since permeability is a main determinant of vascular function
we studied if radiation and melatonin could modulate it.
Radiation increased endothelial cell permeability and melatonin
counteracted the stimulatory effect of radiation. Recently,
it has been described that radiation enhances endothelial
cell permeability through changes in VE-cadherin (Kishimoto
et al., 2018). VE-cadherin is one of the most important
junction proteins of the endothelial cells that regulates vascular
permeability (Rho et al., 2017) and is accumulated in cell
to cell contact. However, radiation induced an intracellular
accumulation of VE-cadherin. Melatonin counteracted the effects
of radiation and decreased the levels of intracellular VE-cadherin.
It is known that phosphorylation and internalization of VE-
cadherin led to an increase of endothelial cell permeability,
which is involved in tumor angiogenesis (Rho et al., 2017).
Phosphorylation and internalization of VE-cadherin is induced
by permeability-increasing agents, such as VEGF (Gavard, 2014).
Again, the inhibition of VEGF by melatonin could explain
the inhibition of cell permeability exerted by melatonin. In
addition, the MAPK/ERK and PI3K/AKT pathways are also
involved in VEGF-induced permeability in HUVECs (Jiang
and Liu, 2008). Thus, melatonin could inhibit endothelial
cell permeability by regulating the internalization of VE-
cadherin, through the inhibition of VEGF and by reducing the
phosphorylation of AKT and ERK.
In the CAM assay, an in vivo model of neovessel formation,
melatonin increased the reduction of the vascular area induced
by radiation. To our knowledge this is the first time that the
inhibition of angiogenesis by melatonin in combination with
ionizing radiation is described in this in vivo model.
Radiation kills cancer cells but, sometimes, induces a
more aggressive and malignant postradiation tumor, due to
the development of resistant cancer cells with increased
proliferative, invasive and angiogenic properties. In order to
improve its effectiveness there is growing interest in combining
radiotherapy with other therapies, such as antiangiogenic or
immune therapies (Goedegebuure et al., 2019). The effects
of ionizing radiation on angiogenesis depend on the balance
between angiogenic promoters and inhibitors and the expression
of the different genes involved in this process must be
coordinated both quantitatively and temporally to ensure correct
angiogenesis. In our study, melatonin treatment counteracted
some of these negative actions of radiation and coordinated
better the balance between stimulating factors and inhibitors
of angiogenesis.
In summary, the results of our study indicate that melatonin
enhances the inhibitory effects on angiogenesis induced by
radiation in human endothelial cells. Melatonin potentiated
antiangiogenic actions and enhanced radiation-induced
inhibitory effect on several steps of the angiogenic process
(cell proliferation, tubular network formation), on the enzymes
involved in estrogen biosynthesis (aromatase mRNA expression,
aromatase promoter I.7, sulfatase mRNA expression and
17β-HSD1 activity and expression), on some proangiogenic
factors, such as ANG-2 and VEGF. In addition, melatonin
neutralized the stimulatory effect of radiation on endothelial
cell permeability and on the expression of some proangiogenic
genes, like FGFR3, TGFα, IGF-1, KDR, JAG1, MMP14, CXCL6,
CCL2, ERK1, ERK2, and AKT1. In vivo, melatonin also
counteracted the stimulatory effect of VEGF on angiogenesis
and enhanced the inhibitory effect of radiation. Antiangiogenic
effect of melatonin could be mediated through AKT and ERK
pathways since melatonin potentiated the inhibitory effect
on the activation of p-AKT and p-ERK exerted by radiation.
Furthermore, melatonin can also inhibit VEGF-induced
angiogenesis by reducing cell permeability and influencing
the internalization of VE-cadherin. One of the most valuable
part of this work have been to demonstrate that radiation
has some side effects on angiogenesis that may reduce its
effectiveness against tumor growth and that melatonin is able
to neutralize these negative actions of ionizing radiation. Our
study has some limitations, as we measured mRNA expression
of several proteins involved in angiogenesis but we did not
measured protein content in all of them. This melatonin
radiosensitive effect may allow to reduce the dose of radiation,
thus enhancing its antitumor action. Our findings point to
melatonin as a useful molecule as adjuvant to radiotherapy in
cancer treatment.
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